Physician

Jake Fagan, MD

According to 2025 Medicare claims, Jake Fagan, MD (NPI: 1548688989) practices micrographic dermatologic surgery in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84604-3305. Fagan is affiliated with the Billings Clinic (ACO ID: A1652) and Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under both the MSSP and REACH models.

Fagan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 580 traditional Medicare patients, billed 1,968 HCPCS/CPT codes, and received $309,633 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 219 prescription claims across 178 beneficiaries totaling $2,223 in drug costs, led by Cephalexin (Cephalexin). Open Payments data shows 6 records totaling $123. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,979 and ending at $2,223. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$166K$332K2019 Medicare payment: $136,742 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $313,596 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $330,049 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $326,563 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $331,555 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $309,633 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019284875$136,742
20206302,145$313,596
20217042,394$330,049
20227002,461$326,563
20237812,701$331,555
20245801,968$309,633

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$31K$63K2015 Drug cost: $3,979 (USD; Tot_Drug_Cst)2016 Drug cost: $14,991 (USD; Tot_Drug_Cst)2017 Drug cost: $62,557 (USD; Tot_Drug_Cst)2018 Drug cost: $34,862 (USD; Tot_Drug_Cst)2019 Drug cost: $2,213 (USD; Tot_Drug_Cst)2020 Drug cost: $5,234 (USD; Tot_Drug_Cst)2021 Drug cost: $6,620 (USD; Tot_Drug_Cst)2022 Drug cost: $4,499 (USD; Tot_Drug_Cst)2023 Drug cost: $15,532 (USD; Tot_Drug_Cst)2024 Drug cost: $2,223 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154678$3,979
201682151$14,991
201783200$62,557
201859118$34,862
20197187$2,213
2020166205$5,234
2021191261$6,620
2022187245$4,499
2023205263$15,532
2024178219$2,223

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks345421$321
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks166291$228
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more157171$47
11102Biopsy of related skin growth, first growth9397$30
17000Destruction of precancer skin growth, 1 growth9395$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CephalexinCephalexin98539$500
FluorouracilFluorouracil11344$498
Doxycycline MonohydrateDoxycycline Monohydrate25447$315
MupirocinMupirocin22310$210
Mometasone FuroateMometasone Furoate11214$149

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$123ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jake Fagan, MD?

Tedicare shows public-source Medicare data for Jake Fagan, MD (NPI 1548688989), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jake Fagan, MD have ACO affiliation data?

Jake Fagan, MD is shown with ACO affiliation data for Billings Clinic (MSSP, ACO ID A1652) and Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to Jake Fagan, MD?

Jake Fagan, MD is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does Jake Fagan, MD have Open Payments data?

Jake Fagan, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.